Related Experiment Video
Updated: Feb 6, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice
Stefano Cataldi1, Jordan Follett1, Jesse D Fox1
11Centre for Applied Neurogenetics, University of British Columbia, Vancouver, Canada.
Abstract:
Vacuolar protein sorting 35 (VPS35) is a core component of the retromer trimer required for endosomal membrane-associated protein trafficking. The discovery of a missense mutation, Vps35 p.D620N implicates retromer dysfunction in the pathogenesis of Parkinson's disease (PD). We have characterized a knock-in mouse with a Vps35 p.D620N substitution (hereafter referred to as VKI) at 3 months of age. Standardized behavioral testing did not observe overt movement disorder. Tyrosine hydroxylase (TH)-positive nigral neuron counts and terminal expression in striata were comparable across genotypes. Fast scan cyclic voltammetry revealed increased dopamine release in VKI striatal slices. While extracellular dopamine collected via striatal microdialysis of freely moving animals was comparable across genotypes, the ratio of dopamine metabolites to dopamine suggests increased dopamine turnover in VKI homozygous mice. Western blot of striatal proteins revealed a genotype-dependent decrease in dopamine transporter (DAT) along with an increase in vesicular monoamine transporter 2 (VMAT2), albeit independent of changes in other synaptic markers. The reduction in DAT was further supported by immunohistochemical analysis. The data show that the dopaminergic system of VKI mice is profoundly altered relative to wild-type littermates. We conclude early synaptic dysfunction contributes to age-related pathophysiology in the nigrostriatal system that may lead to parkinsonism in man.
Insights
A Parkinson's disease-associated mutation in VPS35 causes early synaptic alterations in mice, including altered dopamine transporter levels, suggesting early dysfunction in the nigrostriatal system.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Vacuolar protein sorting 35 (VPS35) is crucial for endosomal trafficking.
- A VPS35 mutation (p.D620N) is linked to Parkinson's disease (PD) pathogenesis.
- Retromer dysfunction is implicated in neurodegenerative diseases.
Purpose of the Study:
- To investigate the early effects of the Vps35 p.D620N mutation on the dopaminergic system in a mouse model.
- To determine if this mutation causes synaptic dysfunction in the nigrostriatal pathway.
Main Methods:
- Generated a knock-in mouse model (VKI) with the Vps35 p.D620N substitution.
- Conducted behavioral tests, nigral neuron counts, and striatal terminal analysis.
- Utilized fast scan cyclic voltammetry, microdialysis, Western blot, and immunohistochemistry.
Main Results:
- No overt movement disorder or loss of dopaminergic neurons observed at 3 months.
- Increased dopamine release and turnover in VKI mice striata.
- Reduced dopamine transporter (DAT) and increased vesicular monoamine transporter 2 (VMAT2) in VKI striata.
Conclusions:
- The Vps35 p.D620N mutation profoundly alters the dopaminergic system early in life.
- Early synaptic dysfunction in the nigrostriatal system may contribute to Parkinson's disease.
- This mouse model provides insights into the pathophysiology of Parkinson's disease.
More Related Videos
Related Concept Videos
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Secondary Active Transport
Energy-releasing Steps of Glycolysis
The first energy-releasing step—the 6th step of glycolysis...
Primary Active Transport
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Electron Transport Chains
The ETC is comprised of...

